|
BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy
RECRUITINGPhase 3Sponsored by Braveheart Bio, Inc.
Actively Recruiting
PhasePhase 3
SponsorBraveheart Bio, Inc.
Started2026-09-02
Est. completion2028-10
Eligibility
Age18 Years – 85 Years
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →
NCT07755904
Summary
The main purpose of this trial is to find out whether BHB-1893 works better than metoprolol in adults with symptoms of obstructive hypertrophic cardiomyopathy (oHCM). The trial includes adults who are currently being treated for oHCM or who have not yet been treated.
Eligibility
Age: 18 Years – 85 YearsHealthy volunteers accepted
Key Inclusion Criteria: * Diagnosed with oHCM per the protocol specified criteria * NYHA Class II or III at screening visits * KCCQ-CSS that meets the protocol specified criteria at screening visits * Adequate acoustic windows for echocardiography Key Exclusion Criteria: * Medical indication for either β-blocker or calcium-channel blocker therapy, other than oHCM, prohibiting drug discontinuation * History of intolerance or medical contraindication to β-blocker therapy * Resting systolic blood pressure (SBP) of \>160 millimeters of mercury (mmHg) at screening visits * Resting heart rate of \>100 beats per minute (bpm) at screening visits * Significant valvular heart disease, defined as: * Moderate to severe valvular aortic stenosis or fixed subaortic obstruction; * Mitral regurgitation not due to systolic anterior motion of the mitral valve (per Investigator's judgment) Other protocol-defined criteria apply.
Conditions2
Cardiomyopathy, Hypertrophic ObstructiveHeart Disease
Interventions2
Locations3 sites
New York
1 siteLIONHEART-HCM Site 0107
South Carolina
1 siteLIONHEART-HCM Site 0126
Texas
1 siteLIONHEART-HCM Site 0121
Find trials near these locations
Related trials
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 3
SponsorBraveheart Bio, Inc.
Started2026-09-02
Est. completion2028-10
Eligibility
Age18 Years – 85 Years
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →
NCT07755904